[SYRE] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
29-Jun-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -1,078.38%
YoY- -872.45%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 0 1,042 0 688 198 168 174 -
PBT -43,825 -63,180 -40,104 -217,074 -18,458 -18,784 -18,443 77.97%
Tax -32 -5,746 3 7 -36 38 -209 -71.34%
NP -43,857 -63,180 -40,107 -217,081 -18,422 -18,822 -18,234 79.42%
Tax Rate - - - - - - - -
Total Cost 43,857 64,222 40,107 217,769 18,620 18,990 18,408 78.28%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin 0.00 -6,063.34 0.00 -31,552.47 -9,304.04 -11,203.57 -10,479.31 -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -1.20 -11.29 -9.34 -56.79 -4.89 -7.20 -4.84 -60.50%
EPS Diluted -1.20 -11.29 -9.34 -56.79 -4.89 -7.20 -4.84 -60.50%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.